Peter Hawkins

6PUBLICATIONS
8CO-AUTHORS
Memory and attentionCognitionNeurology and neuromuscular diseasesPharmaceutical delivery technologiesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 11, 2026
Enhancement of memory network activity in schizophrenia patients by phosphodiesterase-4 (PDE4) inhibitor, roflumilast: A pilot study.

Klaudia Stanoch, Donni Ann Staley, Peter Hawkins

|Dec 01, 2023
Preliminary evidence that ketamine alters anterior cingulate resting-state functional connectivity in depressed individuals.

Laith Alexander, Peter C T Hawkins, Jennifer W Evans

|Apr 28, 2021
Preliminary evidence for the phosphodiesterase type-4 inhibitor, roflumilast, in ameliorating cognitive flexibility deficits in patients with schizophrenia.

Nicholas R Livingston, Peter Ct Hawkins, James Gilleen

|Mar 05, 2021
The effect of risperidone on reward-related brain activity is robust to drug-induced vascular changes.

Peter C T Hawkins, Fernando O Zelaya, Owen O'Daly

Pageof 1